Study Reports Middle Managers' Pay Rising At Biotech Firms

Author: EDWARD R. SILVERMAN, p.21 Editor's Note: The following discussion of the salaries of mid-level managers and scientific staffers at biotechnology companies is the first in a two-part series. The second part, which will appear in the May 27, 1991, issue of The Scientist, will deal with the salaries of executives at biotech firms. While base pay for scientific managers is rising significantly at United States biotechnology companies, there appears to be no dramatic movement upward in sal

Edward Silverman
Apr 28, 1991

Author: EDWARD R. SILVERMAN, p.21

Editor's Note: The following discussion of the salaries of mid-level managers and scientific staffers at biotechnology companies is the first in a two-part series. The second part, which will appear in the May 27, 1991, issue of The Scientist, will deal with the salaries of executives at biotech firms.

While base pay for scientific managers is rising significantly at United States biotechnology companies, there appears to be no dramatic movement upward in salaries for bench-level scientists. These are among the findings of an annual survey of employees of biotech firms conducted by J. Robert Scott, a Boston-based executive search firm specializing in technology, and the Boston-based National High Technology Group of Coopers & Lybrand, an accounting and consulting firm.

The study found that two-thirds of the middle managers working in research and development who were surveyed are receiving more than $50,000 in base salary, whereas...